bms-866949
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2009 (NCT00949767)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glutamate [NMDA] receptor subunit 3AANTAGONIST
GRIN3A antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bms-866949
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01124344 | Phase 1 | May 1, 2010 | Bristol-Myers Squibb |
| NCT00949767 | Phase 1 | Jul 1, 2009 | Bristol-Myers Squibb |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | For profit | 2 | 2 | 1 | 2009 |
1 organizations
Page 1 / 1